← Back to All Filings

Quest Diagnostics Director Files Intent to Sell $240K in Stock

Low SignificanceNovember 25, 2025 at 10:02:22 AM EST

QUEST DIAGNOSTICS INC

$DGX144CIK: 0001022079

Subscribe to track DGX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Quest Diagnostics Director Files Intent to Sell $240K in Stock

Company: Quest Diagnostics Inc. (DGX) Form: 144 | Filed: 2025-11-25 Significance: Low

Insider: Gregg Vicky B Title: Director | Relationship: Director

Transaction: • Type: Proposed Sale • Shares: 1,250 • Price: ~$191.76 • Value: $239,700 • Owned After: Not Disclosed

Key Insight: A director has filed a notice of intent to sell a small amount of stock, representing a negligible fraction (<0.002%) of the company's market cap and shares outstanding.

Market Context: This is a routine filing with low market impact, common for insiders managing personal finances or diversifying assets acquired via compensation.

Comprehensive Analysis

SEC Filing Analysis: Quest Diagnostics Inc. (DGX)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director filed a notice of intent for a minor sale of common stock, representing an insignificant portion of the company's market capitalization.
  • Market Impact: Negligible. The transaction is too small to be considered a material event or to influence market sentiment.

Company Information

FieldValue
CompanyQuest Diagnostics Inc.
Ticker SymbolDGX
CIK0001022079
IndustryMedical Laboratories

Insider Information

FieldValue
NameGregg Vicky B
CIK0001510304
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type144
Transaction Date2025-11-25 (Approximate Sale Date)
Transaction CodeS (Proposed Sale)
Security TypeCommon Stock
Shares Involved1,250
Price Per Share$191.76 (Calculated)
Total Value$239,700
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$239,700
% of Market Cap0.0012%
Shares Transacted1,250
% of Shares Outstanding0.0011%
Post-Transaction OwnershipNot Disclosed
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a large-cap company with a market capitalization of $20.80 billion, a transaction valued at approximately $240,000 is financially immaterial.
  • Transaction Significance: The sale represents a negligible fraction of both the market capitalization and the total shares outstanding, falling far below the thresholds for moderate or high significance. Such trades are typically considered routine portfolio management by insiders.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The size of the proposed sale is insignificant relative to the company's scale and daily trading volume. It does not provide a meaningful signal regarding the insider's outlook on the company's future performance.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The 1,250 shares will be easily absorbed by the market without any noticeable impact on trading volume.
  • Sentiment Indicator: Neutral. The filing is unlikely to influence investor sentiment due to its small size and routine nature.

Additional Context

Transaction Notes

  • This Form 144 filing represents a notice of proposed sale and does not confirm that the sale has been executed. The shares intended for sale were acquired through compensation (restricted stock vesting) and dividend reinvestment plans, which are common sources of insider holdings.
Topics:#QuestDiagnostics#DGX#InsiderTrading#SECFiling#Form144#InsiderSell#StockMarket#Investing#HealthcareStocks

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.